About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Hester Biosciences Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
524669
ISIN Demat
INE782E01017
Book Value
421.62
NSE Code
HESTERBIO
Dividend Yield %
0.48
Market Cap
12370.26
P/E
34.99
EPS
41.56
Face Value
10
BSE
NSE
12-Mar-2026 12:24
BSE
NSE
NSE F & O
12-Mar-2026 12:19
BSE
NSE
NSE F & O
Last Price
1454.15
Net Change
10.65
% Change
0.74%
Prev.Close
1443.50
Open
1440.00
High
1454.15
Low
1423.55
Volume
870
Last Price
1456.80
Net Change
6.1
% Change
0.42%
Prev.Close
1450.70
Open
1450.70
High
1457.50
Low
1424.10
Volume
1786
Value
1265110.5
Best Buy
1443.85
Best Sell
1454.65
Best Quantity
12
Sell Quantity
1
Today's Range
1454.15
52-Week High
2347.70
52-Week Low
1246.75
Value
2601844.8
Best Buy
1450.20
Best Sell
1455.80
Best Quantity
1
Sell Quantity
3
Today's Range
1457.50
52-Week High
2350.00
52-Week Low
1242.95
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
12
Price
1443.85
Quantity
1
Price
1454.65
Best Bid
Best Offer
Quantity
1
Price
1450.20
Quantity
3
Price
1455.80
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Bonus
1 : 2
27-Sep-12
Book Closure
23-Aug-24
29-Aug-24
Rights
2 : 5
05-Jun-06
Dividend
70 %
06-Aug-25
Company News
11-03-2026
Hester Biosciences gets n...
11-03-2026
Hester Biosciences inform...
05-02-2026
Hester Biosciences inform...
02-02-2026
Hester Biosciences inform...
27-01-2026
Hester rises on getting m...
27-01-2026
Hester gets manufacturing...
30-12-2025
Hester Biosciences inform...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.